Repaglinide (Prandin, GlucoNorm) Drug for Diabetes: Use, Side Effects, Interactions

Repaglinide
(Prandin, United States, GlucoNorm, Canada)

Use:

Repaglinide or Prandin is indicated for use in type 2 diabetes.

How It Works:

Repaglinide or Prandin stimulates the pancreas to secrete insulin. This action is similar to sulfonylurea's, but Repaglinide or Prandin represents a structurally different group - the meglitinides.
In type 2 diabetes, the pancreas does still function to produce some insulin - just not enough. In type 1 diabetes, the pancreas does not produce any insulin, thus Repaglinide or Prandin is not indicated for type 1 diabetes.

Side Effects:

As with all diabetic drugs, hypoglycemia is a potential side effect - too low a blood sugar.

Cautions for People:

People with type 1 diabetes cannot use Repaglinide or Prandin. Their pancreases do not produce insulin, thus Repaglinide or Prandin has no potential action.

Drug Interactions:

Repaglinide or Prandin can be taken with other diabetes medication to control their blood sugar.

Further Reading:

Diabet Med 1996Sept;13(9 Suppl6):143

Added to Virtual Drugstore May 1998.
Revised September 1999.

The relevant product monographs must be regarded as the appropriate sources of prescribing information.